MGI Tech Launches Experience Center in Brazil for Latin American Genomics

MGI Tech Launches Experience Center in Brazil for Latin American Genomics

The laboratory has state-of-the-art technology to support medical research in clinical labs and healthcare institutions, improving precision diagnoses and treatments. The agricultural sector can also benefit.

Contributing to the advancement of genomics in Latin AmericaMGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil.

Commitment to Brazil Healthcare

The goal is to provide a facility for clinical and research laboratories, hospitals, and universities to enhance learning and experience with genetic sequencing technology, which is applied in precision medicine, oncology, agrigenomics (the application of the genome in agriculture), and metagenomics (the collection of genomes of environmental microbial communities), among other segments.

The MGI Brazil Customer Experience Center
The MGI Brazil Customer Experience Center

“Genomic research has grown exponentially in the region. As the demand for next-generation sequencing tests in cancer diagnostics and genetic screening increases, hospitals, clinics, laboratories, and universities need to rely on supporting laboratories to improve their capabilities with affordable solutions, faster sample processing speed, and high data quality,” says Carlos Carpio, Senior Commercial Director of MGI LATAM and General Manager of MGI Brazil.

The MGI Brazil Customer Experience Center
The MGI Brazil Customer Experience Center

“Our Customer Experience Center will be able to contribute significantly to the scientific development of the region by reducing sequencing costs, expanding clinical applications and, therefore, making precision diagnoses and treatments more accessible to the population”, he adds.

The lab will also play a role as MGI Hub in Brazil, allowing the expansion of operations across Latin America. It demonstrates MGI’s enduring dedication to broadening global genomics accessibility in this region. MGI has been operating in Latin Americas since 2019 and has already partnered with many clients, such as Fundação Oswaldo Cruz (Fiocruz) in Brazil, Biogenar in Argentina, Gencell in Colombia, Genos in Mexico and TCL Group in Chile.

Automation products in the lab
Automation products in the lab

In Brazil, MGI’s technology also supports the largest Brazilian genomic sequencing project, which aims to sequence the complete genomes of thousands of patients with rare diseases and hereditary cancers, searching for genetic markers to track inherited diseases for early diagnosis. Coordinator of the genomic project, Dr. João Bosco de Oliveira Filho highlights MGI’s technology: “I had a wonderful experience working with MGI’s team. The technology is solid, the data quality is outstanding, and the support is available when needed”, he also welcomes the importance of the launch of the CEC: “Researchers and diagnostic laboratories need to stay up-to-date on available technologies to advance their studies and tests; therefore, it is very important to have a local support laboratory and service personnel.”

State-of-the-art technology provided in the Lab

MGI operates in 100 countries and has nine other customer experience centers worldwide. The Brazilian center in Brooklin Paulista, in São Paulo, will provide a place for clinical laboratories, universities, and hospitals to engage in demonstrations, enhancing their education and experience with the company’s technology. Highly skilled professionals will lead certified training sessions, demonstrations, evaluations and local new application support.

CEC, which covers 270 m2, comprises four distinct areas: the NGS (Next Generation Sequencing) lab, the automation lab, the BIT lab, and the engineering lab.

MGI’s sequencing experience features the high-throughput sequencer DNBSEQ-T7, the high-speed sequencer DNBSEQ-G99, the robust and flexible DNBSEQ-G400, and the portable and easy-to-use sequencer DNBSEQ-E25*.

Also Read: Salesforce in Advanced Talks to Buy Informatica

At the automation lab, the company offers access to cutting-edge technology, including sample preparation systems MGISP-100 and MGISP-960, high- and low-throughput automated nucleic acid extractors MGISP-384 and MGISP-NE32, and an automated sample transfer processing system MGISTP-7000.

Bioinformatics products include ZTRON Pro, a data processing platform and storage, and MegaBOLT, a bioinformatics analysis accelerator series.